PubMed:32736597 / 4329-4513
Annnotations
LitCovid-OGER-BB
{"project":"LitCovid-OGER-BB","denotations":[{"id":"T96","span":{"begin":117,"end":121},"obj":"CHEBI:23888"},{"id":"T97","span":{"begin":117,"end":121},"obj":"CHEBI:23888"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Furthermore, all subjects will receive periodic ePROs which may be completed through smartphone or tablets to record drug self-administration and onset of any symptom or adverse event."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T32","span":{"begin":117,"end":121},"obj":"Chemical"}],"attributes":[{"id":"A32","pred":"chebi_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Furthermore, all subjects will receive periodic ePROs which may be completed through smartphone or tablets to record drug self-administration and onset of any symptom or adverse event."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T30","span":{"begin":0,"end":184},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, all subjects will receive periodic ePROs which may be completed through smartphone or tablets to record drug self-administration and onset of any symptom or adverse event."}